FDA Definition of a Medical Device: Classes, Costs, and Penalties

The FDA classifies every medical device into one of three risk-based groups: Class I for the lowest-risk products like tongue depressors and elastic bandages, Class II for moderate-risk products like infusion pumps and powered wheelchairs, and Class III for the highest-risk products like pacemakers and replacement heart valves.1U.S. Food and Drug Administration. Overview of Medical Device Classification and Reclassification The class assignment decides how a manufacturer gets to market, what it pays in user fees, and what quality and reporting obligations follow the product for its entire commercial life. Getting the FDA medical device classification wrong is not a paperwork problem. Civil penalties reach $1,000,000 per proceeding, and criminal penalties can include prison time.

What Qualifies as a Medical Device

Before classification even comes up, a product has to fit the statutory definition. Section 201(h) of the Federal Food, Drug, and Cosmetic Act covers instruments, apparatus, implants, in vitro reagents, and similar articles (including components and accessories) that are recognized in the U.S. Pharmacopeia or National Formulary, intended to diagnose, cure, treat, or prevent disease, or intended to affect the structure or function of the body.2Office of the Law Revision Counsel. 21 U.S. Code 321 – Definitions; Generally

The line between a device and a drug turns on mechanism. A device does not achieve its primary intended purpose through chemical action in or on the body and is not dependent on being metabolized. An insulin pump is a device because it mechanically delivers a substance; the insulin itself is a drug because it acts chemically.2Office of the Law Revision Counsel. 21 U.S. Code 321 – Definitions; Generally Intended use drives the analysis, and the FDA reads intended use from labeling, marketing claims, and manufacturer statements. Cosmetics, food, and dietary supplements sit outside the device definition entirely and have their own regulatory pathways.3U.S. Food and Drug Administration. Dietary Supplements

Class I: Lowest Risk

Class I is the floor. Roughly 74% of Class I device types are exempt from the 510(k) premarket notification process, so manufacturers can ship the product without FDA clearance of that specific device.4U.S. Food and Drug Administration. Classify Your Medical Device Some are also exempt from parts of the quality system requirements, though complaint files and records still have to be kept.5eCFR. 21 CFR Part 880 – General Hospital and Personal Use Devices

Exempt does not mean unregulated. Every Class I manufacturer still registers its establishment annually, lists its devices, follows labeling rules, and reports adverse events. To check whether a specific device qualifies for exemption, the FDA maintains a searchable database of exempt device types organized by product code.

Class II: Moderate Risk

Class II devices carry moderate risk and require both General Controls and Special Controls. Special Controls are tailored to the device type and can include performance standards, specific labeling requirements, post-market surveillance studies, or patient registries.6eCFR. 21 CFR 860.3 – Definitions

Most Class II devices reach market through the 510(k) premarket notification process. The manufacturer demonstrates that its device is “substantially equivalent” to a legally marketed predicate device, meaning it has the same intended use and either the same technological characteristics or different characteristics that do not raise new safety or effectiveness concerns. The FDA’s review target is 90 days from submission to decision.7U.S. Food and Drug Administration. FDA-TRACK – Medical Device User Fee Amendments Review Goals Summary

For a first-of-its-kind device that has no predicate but does not warrant Class III, the De Novo pathway offers an alternative. A De Novo request asks the FDA to create a new classification in Class I or Class II, and once granted, that device becomes a predicate future 510(k) submissions can cite. The FDA targets 150 review days for De Novo decisions.8U.S. Food and Drug Administration. De Novo Classification Request

Class III: Highest Risk

Class III covers devices that support or sustain life, are of substantial importance in preventing serious health impairment, or present a potential unreasonable risk of illness or injury. Pacemakers, replacement heart valves, and implantable defibrillators are the archetypes.9U.S. Food and Drug Administration. PMA Approvals

The standard pathway is Premarket Approval (PMA), which requires clinical trial data proving both safety and effectiveness. The FDA’s review target is 180 days when no advisory committee input is needed and 320 days when it is.7U.S. Food and Drug Administration. FDA-TRACK – Medical Device User Fee Amendments Review Goals Summary Before running those trials, a manufacturer typically needs an Investigational Device Exemption (IDE), which requires a detailed investigational plan, risk analysis, and evidence of Institutional Review Board approval.10eCFR. 21 CFR Part 812 – Investigational Device Exemptions

One wrinkle catches manufacturers by surprise. Many Class III device types that were on the market before the modern classification system took effect (so-called preamendments devices) have never been called in for PMA review because the FDA has not set an effective date requiring it. Those device types currently reach market through 510(k) instead. The FDA can require PMAs at any time by publishing a regulation, so this category lives with ongoing uncertainty.11U.S. Food and Drug Administration. PMA Historical Background

For devices intended to treat or diagnose conditions affecting no more than 8,000 people in the United States per year, the Humanitarian Device Exemption (HDE) offers a lighter pathway. An HDE requires evidence of safety and probable benefit but does not require clinical evidence of effectiveness, which makes it workable for ultra-rare conditions where large clinical trials cannot recruit enough patients.12U.S. Food and Drug Administration. Humanitarian Device Exemption

Requirements That Apply to Every Class

General Controls form the regulatory floor for all devices regardless of class. They cover annual establishment registration, device listing, labeling, adverse event reporting, device tracking for certain products, participation in the Unique Device Identification (UDI) system, and compliance with quality system requirements.13U.S. Food and Drug Administration. Regulatory Controls General Controls also give the FDA authority to ban dangerous devices and order mandatory recalls.

Under UDI, every device label and package carries a unique identifier in both plain text and machine-readable form. The identifier has a device identifier segment identifying the manufacturer and product, plus a production identifier for lot number, serial number, manufacturing date, or expiration date where applicable.14eCFR. 21 CFR Part 801 Subpart B – Labeling Requirements for Unique Device Identification

On February 2, 2026, the FDA’s Quality Management System Regulation (QMSR) replaced the former Quality System Regulation under 21 CFR Part 820. The QMSR aligns FDA manufacturing requirements with ISO 13485:2016, the international standard used by regulators worldwide.15U.S. Food and Drug Administration. Quality Management System Regulation – Frequently Asked Questions Manufacturers already certified to ISO 13485 have a simpler path; those who were not now have to adopt the international standard’s framework for design controls, production, corrective actions, and management review.

What Each Pathway Costs

Manufacturers pay user fees annually for establishment registration and per submission for premarket applications. The fiscal year 2026 rates are:

A business qualifies for reduced fees if its gross receipts, including all affiliates, do not exceed $100 million. Companies with gross receipts of $30 million or less may qualify for a complete waiver of their first premarket application fee. The smallest firms, those with gross receipts of $1 million or less, may qualify for a waiver of the registration fee on a showing of financial hardship.18U.S. Food and Drug Administration. Reduced or Waived Medical Device User Fees – Small Business Determination (SBD) Program

The gap between pathways is dramatic. A small-business 510(k) filer pays $6,517; the same company filing a PMA pays $144,818 in fees before it spends a dollar on the clinical trials required to support the application. Classification decisions have direct budget consequences.

Post-Market Reporting and Recalls

Clearance or approval is the start of the compliance calendar, not the end. If a manufacturer learns that a marketed device may have caused or contributed to a death, serious injury, or a malfunction that could lead to either, it must submit a Medical Device Report (MDR) to the FDA within 30 calendar days. Where the event requires immediate corrective action to prevent an unreasonable public health risk, the deadline compresses to five business days.19eCFR. 21 CFR Part 803 – Medical Device Reporting

Hospitals and other user facilities have a separate obligation: report device-related deaths or serious injuries within 10 business days of becoming aware of them.19eCFR. 21 CFR Part 803 – Medical Device Reporting

The FDA also assigns recall classifications, which are separate from device classifications and confusingly numbered in reverse. A Class I recall indicates the most serious health hazard; Class II and Class III recalls involve progressively lower risk. The FDA weighs whether injuries have already occurred, the seriousness of the potential hazard, and the likelihood of harm when assigning these designations.20eCFR. 21 CFR Part 7 Subpart C – Recalls

Penalties for Getting It Wrong

Marketing a device that is misbranded, adulterated, or sold without required clearance or approval carries both criminal and civil exposure. A first criminal violation can bring up to one year in prison, a $1,000 fine, or both. Where the violation involves intent to defraud, or the person has a prior conviction, the penalties rise to up to three years in prison and a $10,000 fine.21Office of the Law Revision Counsel. 21 U.S. Code 333 – Penalties

Civil penalties for device violations can reach $15,000 per violation and $1,000,000 for all violations in a single proceeding. Knowingly dealing in counterfeit devices carries the harshest penalty of all: up to 10 years in prison.21Office of the Law Revision Counsel. 21 U.S. Code 333 – Penalties Beyond formal penalties, the FDA can issue warning letters, seize product, and seek injunctions that stop manufacturing operations.